The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
The Stock Idea & Analysis Community
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

 Ahithophel Weissberger     Graphic_subscribe   

    Start Tracking Ahithophel Weissberger   
    This is a Tracking Account  |  Tracked since 06/08/2008  [?]     SocialPicks is not affiliated with Ahithophel Weissberger
This is a partial compilation of Ahithophel Weissberger's posts and is not meant as a complete representation of the blogger's performance.


 Last Activity: Added MNKD to bullish list on 06/22/08 

Current Stock List:
Symbol SP Sentiment Rating Return Since
MNKD Positive +138.49% 06/22/08




Blog Posts

Graphic_rating_buy MNKD   Mannkind: Overlooked Biotech With Excellent Prospects (Part VI) 06/22/08   —  Part VI: Conclusion – Summary, valuation, and risks This is the final part of my six-part series on Mannkind (MNKD). Be sure to see Part 1, Part 2, Part 3, Part 4, and Part 5, if you have not done so already. I will now summarize the key points and get into valuation. Mannkind is a development-stag...
+ Read 0 comments

Graphic_rating_buy MNKD   PFE   Mannkind: Overlooked Biotech With Excellent Prospects (Part V) 06/19/08   —  Part V: Mannkind’s (MNKD) pipeline potential This is part 5 of my six-part series covering Mannkind. In Part 1, I explained why Technosphere Insulin, Mannkind’s upcoming inhaled insulin, is a breakthrough product with the potential to significantly improve diabetes treatment. In Part 2, I exp...
+ Read 0 comments

Graphic_rating_buy MNKD   PFE   Mannkind: Overlooked Biotech With Excellent Prospects (Part IV) 06/17/08   —   Part IV: Mannkind’s (MNKD) partnership opportunities for Technosphere Insulin This is Part 4 of my six-part series covering Mannkind. In Part 1, I explained why Technosphere Insulin, Mannkind’s upcoming inhaled insulin, is a breakthrough product with the potential to significantly improve ...
+ Read 0 comments

PFE   Graphic_rating_buy MNKD   Mannkind: Overlooked Biotech With Excellent Prospects (Part III) 06/13/08   —  Part III: Pfizer (PFE) fails with Exubera; Mannkind (MNKD) forges on with Technosphere Insulin: Why they’re different  This is Part 3 of my six-part series covering Mannkind....
+ Read 0 comments

PFE   Graphic_rating_buy MNKD   Mannkind: Overlooked Biotech With Excellent Prospects (Part II) 06/11/08   —  Part II: Pfizer’s (PFE) cancer announcement and its irrelevance to Mannkind’s (MNKD) future As I explained in detail in Part 1 of this series (see here if you missed it), Mannkind has a potential home run with Technosphere Insulin, their upcoming drug for diabetes. Technosphere Insulin is an ...
+ Read 0 comments



People Following Ahithophel Weissberger ...

Nobody is following Ahithophel Weissberger.






ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.25% 377
2 18.14 +70.10% 208
3 17.66 +25.70% 55
4 13.47 +14.32% 61
5 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Similarity to Me   ?

Compare Your Portfolio With Ahithophel Weissberger:
Enter stocks you like & track your performance:

Symbols, separated by space (e.g. AAPL GOOG MSFT)



More about Ahithophel Weissberger

Avg exp holding time:
88.50 days



Similar Portfolios
Mikerun
Mike Havrilla (mikehav) 73% 100%
Pic
diddydunn (diddydunn) 20% 100%
durai (durai) 82% 100%
Zacks.com (zacks.com) 28% 100%
jhnbsmr2 (jhnbsmr2) 60% 100%



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch